Electrochemically applied hydroxyapatite on the cementless porous surface of Bi-Metric stems reduces early migration and has a lasting effect : an efficacy trial of a randomized five-year follow-up radiostereometric study.

BoneMaster Cementless Femoral stem Hip arthroplasty Hydroxyapatite Radiostereometric analysis (RSA) Radiostereometry cementless femoral stems early stabilization fast femoral stems fixation of stems hydroxyapatite orthopaedic implants osseointegration porous titanium

Journal

The bone & joint journal
ISSN: 2049-4408
Titre abrégé: Bone Joint J
Pays: England
ID NLM: 101599229

Informations de publication

Date de publication:
Jun 2022
Historique:
entrez: 31 5 2022
pubmed: 1 6 2022
medline: 3 6 2022
Statut: ppublish

Résumé

BoneMaster is a thin electrochemically applied hydroxyapatite (HA) coating for orthopaedic implants that is quickly resorbed during osseointegration. Early stabilization is a surrogacy marker of good survival of femoral stems. The hypothesis of this study was that a BoneMaster coating yields a fast early and lasting fixation of stems. A total of 53 patients were randomized to be treated using Bi-Metric cementless femoral stems with either only a porous titanium plasma-sprayed coating (P group) or a porous titanium plasma-sprayed coating with an additional BoneMaster coating (PBM group). The patients were examined with radiostereometry until five years after surgery. At three months, the mean total translation (TT) was 0.95 mm (95% confidence interval (CI) 0.68 to 1.22) in the P group and 0.57 mm (95% CI 0.31 to 0.83) in the PBM group (p = 0.047). From two to five years, the TT increased by a mean of 0.14 mm (95% CI 0.03 to 0.25) more in the P group than in the PBM group (p = 0.021). In osteopenic patients (n = 20), the mean TT after three months was 1.61 mm (95% CI 1.03 to 2.20) in the P group and 0.73 mm (95% CI 0.25 to 1.21) in the PBM group (p = 0.023). After 60 months, the mean TT in osteopenic patients was 1.87 mm (95% CI 1.24 to 2.50) in the P group and 0.82 mm (95% CI 0.30 to 1.33) in the PBM group (p = 0.011). There was less early and midterm migration of cementless stems with BoneMaster coating compared with those with only a porous titanium plasma-sprayed coating. Although a BoneMaster coating seems to be important for stem fixation, especially in osteopenic patients, further research is warranted

Identifiants

pubmed: 35638207
doi: 10.1302/0301-620X.104B6.BJJ-2021-1545.R1
doi:

Substances chimiques

Coated Materials, Biocompatible 0
Durapatite 91D9GV0Z28
Titanium D1JT611TNE

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

647-656

Auteurs

Martin B Knudsen (MB)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
AutoRSA Research Group, Orthopaedic Research Unit, Aarhus University Hospital, Aarhus, Denmark.

Janni K Thillemann (JK)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
AutoRSA Research Group, Orthopaedic Research Unit, Aarhus University Hospital, Aarhus, Denmark.
Department of Orthopaedics, University Clinic for Hand, Hip and Knee Surgery, Gødstrup Hospital, Herning, Denmark.

Peter B Jørgensen (PB)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
AutoRSA Research Group, Orthopaedic Research Unit, Aarhus University Hospital, Aarhus, Denmark.

Stig S Jakobsen (SS)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus, Denmark.

Henrik Daugaard (H)

Department of Orthopaedics, Gentofte Hospital, Copenhagen University Hospital, Hellerup, Denmark.

Kjeld Søballe (K)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus, Denmark.

Maiken Stilling (M)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
AutoRSA Research Group, Orthopaedic Research Unit, Aarhus University Hospital, Aarhus, Denmark.
Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH